| abstract |
New forms of application for α-interferons are described, but in particular for alpha-2-interferons, consisting of a non-lyophilized dry film of acid-stabilized α-interferons, e.g. B. Alpha-2-interferon, on an inert carrier, the carriers preferably a.) From eye sticks with uniformly applied at the ends amounts of α-interferons for ophthalmic use for the entry of the active ingredient in the conjunctival sac or, b.) a dry film ampoule with a film of α-interferons adhering to the inner edges, for the preparation of injection solutions. |